Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

ZZenas BioPharma, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
Z

Zenas BioPharma, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $1M. Net result −$111.46M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $1M. Running result $1M. Revenue: $1M.
  • Cost of revenue: $0. Running result $1M.
  • Gross profit: $1M. Running result $1M.
  • Research and development: −$62.91M. Running result −$61.91M.
  • General and administrative: −$15.75M. Running result −$77.66M.
  • Acquired in-process research and development: −$30M. Running result −$107.66M.
  • Operating income: −$107.66M. Running result −$107.66M.
  • Other expense: −$3.68M. Running result −$111.34M.
  • Pre-tax loss: −$111.34M. Running result −$111.34M.
  • Income tax expense: −$114K. Running result −$111.46M.
  • Net loss: −$111.46M. Running result −$111.46M.